Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.14% | -25.38% | -87.67% | -74.14% | -10.06% |
| Total Depreciation and Amortization | -10.22% | -13.44% | -17.92% | -15.67% | -25.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.01% | -16.14% | 129.16% | 136.68% | 11.87% |
| Change in Net Operating Assets | -67.21% | -122.46% | -51.17% | 278.28% | 215.67% |
| Cash from Operations | -27.80% | -243.82% | -128.92% | 44.74% | 44.97% |
| Capital Expenditure | -62.01% | -35.46% | 2.06% | 0.84% | 45.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -110.90% | -110.72% | -108.53% | -108.86% | 909.63% |
| Total Debt Issued | -- | -- | 268.02% | 268.02% | 268.02% |
| Total Debt Repaid | 99.82% | 99.82% | -26,209.52% | -18,642.37% | -10,640.78% |
| Issuance of Common Stock | 8,039.53% | 8,039.53% | -100.00% | -85.92% | -59.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -124.38% | 28.13% | 167.97% | 172.00% | 172.00% |
| Cash from Financing | -71.83% | -79.03% | 186.68% | 190.01% | 192.18% |
| Foreign Exchange rate Adjustments | 185.25% | 159.16% | 55.04% | -123.66% | -144.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -129.82% | -135.60% | -19.48% | 996.40% | 310.71% |